Prediction of Difficult Mask Ventilation Using 3D-Facescan and Machine Learning (MASCAN)
Proof-of-principle Study for the Prediction of Difficult Mask Ventilation Using 3D-Facescan and Machine Learning
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Martin Petzoldt, MD
- Phone Number: +49 152 2281 5932
- Email: m.petzoldt@uke.de
Study Locations
-
-
-
Hamburg, Germany, 20246
- University Medical Center Hamburg-Eppendorf
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients scheduling for ENT or OMS surgery in general anaesthesia, who require facemask ventilation and tracheal intubation after induction of anesthesia
- Patients aged at least 18 years
- Ability to understand the patient information and to personally sign and date the informed consent to participate in the study
- The patient is co-operative and available for the entire study
- Provided informed consent/patient representative
Exclusion Criteria:
- Pregnant or breastfeeding woman
- Rapid sequence induction or other contraindications for facemask ventilation
- Planned awake tracheal intubation
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Study cohort
Patients undergoing ENT or OMS surgery with general anesthesia with facemask ventilation and tracheal intubation (observational)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difficult facemask ventilation
Time Frame: 1 hour
|
Observed difficult facemask ventilation after induction of anesthesia
|
1 hour
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difficult tracheal intubation
Time Frame: 1 hour
|
Observed difficult intubation after induction of anesthesia
|
1 hour
|
|
Difficult laryngoscopy
Time Frame: 1 hour
|
Observed difficult laryngoscopy after induction of anesthesia
|
1 hour
|
|
Number of attempts
Time Frame: 1 hour
|
Observed during tracheal intubation
|
1 hour
|
|
Failed direct laryngoscopy
Time Frame: 1 hour
|
Observed during airwaymanagement
|
1 hour
|
|
Cormack Lehane grade
Time Frame: 1 hour
|
Grading of the best view obtained during laryngoscopy (I-IV)
|
1 hour
|
|
Difficult mask ventilation alert
Time Frame: 1 hour
|
Noted by the responsible anaesthesiologist after airway management
|
1 hour
|
|
Difficult intubation alert
Time Frame: 1 hour
|
Noted by the responsible anaesthesiologist after airway management
|
1 hour
|
|
Intubation time
Time Frame: 1 hour
|
Recorded during airwaymanagement
|
1 hour
|
|
Time to sufficient mask ventilation
Time Frame: 1 hour
|
Recorded during airwaymanagement
|
1 hour
|
|
Classification of intubation difficulty
Time Frame: 1 hour
|
VIDIAC score rating between -1 and 5 points
|
1 hour
|
|
Percentage of glottis opening (POGO)
Time Frame: 1 hour
|
Grading of the best view obtained during laryngoscopy (%)
|
1 hour
|
|
Impossible facemask ventilation
Time Frame: 1 hour
|
Observed impossible facemask ventilation after induction of anesthesia
|
1 hour
|
|
Successful first attempt intubation
Time Frame: 1 hour
|
Observed during airway management
|
1 hour
|
|
Airway-related adverse events
Time Frame: 1 hour
|
Laryngospasm, bronchospasm, larynx trauma, airway trauma, soft tissue trauma, oral bleeding, edema, dental damage, corticosteroid application, accidental esophageal intubation, aspiration, hypotension or hypoxia
|
1 hour
|
|
Post-intubation recommendation for an intubation method
Time Frame: 1 hour
|
Recommendation of the responsible anaesthesiologist after airwaymanagement
|
1 hour
|
|
Minimal peripheral oxygen saturation (SpO2)
Time Frame: 1 hour
|
Observed after induction of anesthesia
|
1 hour
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Martin Petzoldt, MD, Universitätsklinikum Hamburg-Eppendorf
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 2022-100811-BO-ff
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.